Research authors assessed the safety and efficacy of intravesical bacteriophage therapy compared to placebo and current standard of care for the treatment of urinary tract infection in patients undergoing transurethral resection of the prostate.
Sweta GuptaContributing Writer
Sweta Gupta is a freelance writer and editor with more than 10 years of experience in media and publishing. She started her career at Wiley, editing textbooks on psychology, counseling, and social work. Afterward, she transitioned to working on professional content with Medscape Education, the largest US provider of continuing medical education programs. Most recently, she managed two websites for a clinician audience: Infectious Disease Advisor and Endocrinology Advisor. She is a graduate of Rutgers University and holds a BA in English literature and a minor in psychology.